Dale M Benedict

US Patent:

6753319, Jun 22, 2004

Filed:

Aug 29, 2002

Appl. No.:

10/231399

Inventors:

Dale L. Benedict - Fayetteville AR
Martha Benedict - Fayetteville AR

Assignee:

BioTech Pharmacal, Inc. - Fayetteville AR

International Classification:

A61K 3170

US Classification:

514 35, 514 23, 514843

Abstract:

The present invention concerns the use of D-Mannose to prevent or inhibit uniting of sperm and egg in the conception process. The administration of D-Mannose to a female such that the environment of an egg has sufficient D-Mannose to inhibit interaction of sperm and the egg and prevent or inhibit conception. D-Mannose dosages may be complimentary to other methods of birth control to enhance their effectiveness.

US Patent:

20040180839, Sep 16, 2004

Filed:

Mar 26, 2004

Appl. No.:

10/810522

Inventors:

Dale Benedict - Fayetteville AR,
Martha Benedict - Fayetteville AR,

International Classification:

A61K031/70

US Classification:

514/023000

Abstract:

The present invention concerns the use of D-mannose to prevent or inhibit uniting of sperm and egg in the conception process. The administration of D-Mannose to a female such that the environment of an egg has sufficient D-Mannose to inhibit interaction of sperm and the egg and prevent or inhibit conception. D-Mannose dosages may be complimentary to other methods of birth control to enhance their effectiveness.

US Patent:

20050020510, Jan 27, 2005

Filed:

Aug 18, 2004

Appl. No.:

10/921748

Inventors:

Dale Benedict - Fayetteville AR,

International Classification:

A61K031/70

US Classification:

514023000

Abstract:

The present invention concerns the use of D-mannose to prevent or inhibit uniting of sperm and egg/zygote in the conception process, both for specific target animals as well as general animal populations. It is emphasized that this abstract is provided to comply with the rules requiring an abstract that will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. 37 CFR 1.72(b).

US Patent:

20060211633, Sep 21, 2006

Filed:

May 23, 2006

Appl. No.:

11/439403

Inventors:

Dale Benedict - Fayetteville AR,
Martha Benedict - Fayetteville AR,

International Classification:

A61K 31/70

US Classification:

514023000

Abstract:

The present invention concerns the use of D-mannose to prevent or inhibit uniting of sperm and egg/zygote in the conception process, both for specific target animals as well as general animal populations. It is emphasized that this abstract is provided to comply with the rules requiring an abstract that will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. 37 CFR 1.72(b).

US Patent:

20090105161, Apr 23, 2009

Filed:

Nov 26, 2008

Appl. No.:

12/292816

Inventors:

Dale L. Benedict - Fayetteville AR,
Martha J. Benedict - Fayetteville AR,

Assignee:

Bio-Tech Pharmacal, Inc. - Fayetteville AR

International Classification:

A61K 31/7004
A61P 15/18

US Classification:

514 23

Abstract:

The present invention concerns the use of D-mannose to prevent or inhibit uniting of sperm and egg/zygote in the conception process, both for specific target animals as well as general animal populations. It is emphasized that this abstract is provided to comply with the rules requiring an abstract that will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. 37 CFR 1.72(b).